{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:49Z","timestamp":1792025209274,"version":"4.4.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R03AI156261-01"],"award-info":[{"award-number":["1R03AI156261-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TR002318"],"award-info":[{"award-number":["TR002318"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"CDC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>There is conflicting evidence on whether prior azithromycin (AZM) exposure is associated with reduced susceptibility to AZM (AZMRS) among persons infected with Neisseria gonorrhoeae (NG).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The study population included Public Health\u2013Seattle and King County Sexual Health Clinic (SHC) patients with culture-positive NG infection at \u22651 anatomic site whose isolates were tested for AZM susceptibility in 2012\u20132019. We used multivariate logistic regression to examine the association of time since last AZM prescription from the SHC in \u226412 months with subsequent diagnosis with AZMRS NG (minimum inhibitory concentration [MIC], \u22652.0 \u00b5g\/mL) and used linear regression to assess the association between the number of AZM prescriptions in \u226412 months and AZM MIC level, controlling for demographic, behavioral, and clinical characteristics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 2155 unique patients had 2828 incident NG infections, 156 (6%) of which were caused by AZMRS NG. AZMRS NG was strongly associated with receipt of AZM from the SHC in the prior 29 days (adjusted odds ratio, 6.76; 95% confidence interval [CI], 1.76 to 25.90) but not with receipt of AZM in the prior 30\u2013365 days. Log AZM MIC level was not associated with the number of AZM prescriptions within \u226412 months (adjusted correlation, 0.0004; 95% CI, \u2013.04 to .037) but was associated with number of prescriptions within &amp;lt;30 days (adjusted coefficient, 0.56; 95% CI, .13 to .98).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Recent individual-level AZM treatment is associated with subsequent AZMRS gonococcal infections. The long half-life and persistence of subtherapeutic levels of AZM may result in selection of resistant NG strains in persons with recent AZM use.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciac682","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T15:57:59Z","timestamp":1661356679000},"page":"e1270-e1276","source":"Crossref","is-referenced-by-count":8,"title":["Prior Exposure to Azithromycin and Azithromycin Resistance Among Persons Diagnosed With <i>Neisseria gonorrhoeae<\/i> Infection at a Sexual Health Clinic: 2012\u20132019"],"prefix":"10.1093","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2436-1022","authenticated-orcid":false,"given":"Emily","family":"Rowlinson","sequence":"first","affiliation":[{"name":"Department of Epidemiology, University of Washington , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusegun O","family":"Soge","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington , Seattle, Washington , USA"},{"name":"Neisseria Reference Laboratory, University of Washington , Seattle, Washington , USA"},{"name":"Department of Global Health, University of Washington , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5034-3157","authenticated-orcid":false,"given":"James P","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Washington , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Berzkalns","sequence":"additional","affiliation":[{"name":"HIV\/STD Program, Public Health\u2013Seattle and King County , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Thibault","sequence":"additional","affiliation":[{"name":"HIV\/STD Program, Public Health\u2013Seattle and King County , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne P","family":"Kerani","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Washington , Seattle, Washington , USA"},{"name":"HIV\/STD Program, Public Health\u2013Seattle and King County , Seattle, Washington , USA"},{"name":"Department of Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M","family":"Khosropour","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Washington , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E","family":"Manhart","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Washington , Seattle, Washington , USA"},{"name":"Department of Global Health, University of Washington , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R","family":"Golden","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Washington , Seattle, Washington , USA"},{"name":"Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington , Seattle, Washington , USA"},{"name":"HIV\/STD Program, Public Health\u2013Seattle and King County , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindley A","family":"Barbee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington , Seattle, Washington , USA"},{"name":"HIV\/STD Program, Public Health\u2013Seattle and King County , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"2023053119004053800_ciac682-B1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2023053119004053800_ciac682-B2","doi-asserted-by":"crossref","DOI":"10.15620\/cdc:82532","volume-title":"Antibiotic resistance threats in the United States, 2019","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"2023053119004053800_ciac682-B3","first-page":"1911","article-title":"Update to CDC\u2019s treatment guidelines for gonococcal infection, 2020","volume":"69","author":"St Cyr","year":"2020","journal-title":"MMWR"},{"key":"2023053119004053800_ciac682-B4","volume-title":"Sexually transmitted disease surveillance 2019","author":"Centers for Disease Control and Prevention","year":"2021"},{"key":"2023053119004053800_ciac682-B5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0956462419886775","article-title":"2018 UK national guideline for the management of infection with Neisseria gonorrhoeae","volume":"31","author":"Fifer","year":"2020","journal-title":"Int J STD AIDS"},{"key":"2023053119004053800_ciac682-B6","doi-asserted-by":"publisher","DOI":"10.1177\/0956462420949126","article-title":"2020 European guideline for the diagnosis and treatment of gonorrhoea in adults","author":"Unemo","year":"2020","journal-title":"Int J STD AIDS"},{"key":"2023053119004053800_ciac682-B7","author":"Gonorrhoea\u2014STI guidelines Australia"},{"key":"2023053119004053800_ciac682-B8","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1128\/AAC.00309-10","article-title":"High-Level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes","volume":"54","author":"Chisholm","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2023053119004053800_ciac682-B9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/OLQ.0b013e3182685d2b","article-title":"Emergence of increased azithromycin resistance during unsuccessful treatment of Neisseria gonorrhoeae infection with azithromycin (Portland, OR, 2011)","volume":"39","author":"Soge","year":"2012","journal-title":"Sex Transm Dis"},{"key":"2023053119004053800_ciac682-B10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1258\/0956462971920127","article-title":"Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin","volume":"8","author":"Young","year":"1997","journal-title":"Int J STD AIDS"},{"key":"2023053119004053800_ciac682-B11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/cid\/cix249","article-title":"Decreased azithromycin susceptibility of Neisseria gonorrhoeae isolates in patients recently treated with azithromycin","volume":"65","author":"Wind","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2023053119004053800_ciac682-B12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/sextrans-2017-053461","article-title":"Is previous azithromycin treatment associated with azithromycin resistance in Neisseria gonorrhoeae? A cross-sectional study using national surveillance data in England","volume":"94","author":"Clifton","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2023053119004053800_ciac682-B13","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2021-055298","article-title":"Is there an association between previous infection with Neisseria gonorrhoeae and gonococcal AMR? A cross-sectional analysis of national and sentinel surveillance data in England, 2015\u20132019","author":"Allen","year":"2022","journal-title":"Sex Transm Infect"},{"key":"2023053119004053800_ciac682-B14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/AAC.04337-14","article-title":"Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013","volume":"59","author":"Kirkcaldy","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2023053119004053800_ciac682-B15","author":"Centers for Disease Control and Prevention"},{"key":"2023053119004053800_ciac682-B16","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1097\/OLQ.0000000000001535","article-title":"Implementation and evaluation of gradient strip antimicrobial susceptibility testing in US public health laboratories to respond to resistant gonorrhea","volume":"48","author":"Raphael","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2023053119004053800_ciac682-B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v094.i12","article-title":"PResiduals: an R package for residual analysis using probability-scale residuals","volume":"94","author":"Liu","year":"2020","journal-title":"J Stat Softw"},{"key":"2023053119004053800_ciac682-B18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/infdis\/jiy551","article-title":"Azithromycin susceptibility among Neisseria gonorrhoeae isolates and seasonal macrolide use","volume":"219","author":"Olesen","year":"2019","journal-title":"J Infect Dis"},{"key":"2023053119004053800_ciac682-B19","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1097\/OLQ.0000000000001541","article-title":"Demographic and epidemiological characteristics associated with reduced antimicrobial susceptibility to Neisseria gonorrhoeae in the United States, strengthening the US response to resistant gonorrhea, 2018 to 2019","volume":"48","author":"Gieseker","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2023053119004053800_ciac682-B20","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/infdis\/jiz156","article-title":"Deciphering the impact of bystander selection for antibiotic resistance in Neisseria gonorrhoeae","volume":"221","author":"Olesen","year":"2020","journal-title":"J Infect Dis"},{"key":"2023053119004053800_ciac682-B21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/sextrans-2015-052414","article-title":"Should azithromycin 1 g be abandoned as a treatment for bacterial STIs? The case for and against","volume":"93","author":"Horner","year":"2017","journal-title":"Sex Transm Infect"},{"key":"2023053119004053800_ciac682-B22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"key":"2023053119004053800_ciac682-B23","doi-asserted-by":"crossref","first-page":"e01419","DOI":"10.1128\/mBio.01419-18","article-title":"Azithromycin resistance through interspecific acquisition of an epistasis-dependent efflux pump component and transcriptional regulator in Neisseria gonorrhoeae","volume":"9","author":"Wadsworth","year":"2018","journal-title":"mBio"},{"key":"2023053119004053800_ciac682-B24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.43.6.1367","article-title":"Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes","volume":"43","author":"Roberts","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2023053119004053800_ciac682-B25","doi-asserted-by":"crossref","first-page":"683901","DOI":"10.3389\/fmicb.2021.683901","article-title":"Evidence of horizontal gene transfer of 50S ribosomal genes rplB, rplD, and rplY in Neisseria gonorrhoeae","volume":"12","author":"Manoharan-Basil","year":"2021","journal-title":"Front Microbiol"},{"key":"2023053119004053800_ciac682-B26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/cid\/ciab071","article-title":"The duration of pharyngeal gonorrhea: a natural history study","volume":"73","author":"Barbee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023053119004053800_ciac682-B27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhoea\u2014the rapidly evolving Neisseria gonorrhoeae continues to challenge","volume":"15","author":"Unemo","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2023053119004053800_ciac682-B28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/OLQ.0000000000000844","article-title":"A phase 1 pharmacokinetic and safety study of extended-duration, high-dose cefixime for cephalosporin-resistant Neisseria gonorrhoeae in the pharynx","volume":"45","author":"Barbee","year":"2018","journal-title":"Sex Transm Dis"},{"key":"2023053119004053800_ciac682-B29","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41564-019-0501-y","article-title":"The impact of antimicrobials on gonococcal evolution","volume":"4","author":"S\u00e1nchez-Bus\u00f3","year":"2019","journal-title":"Nat Microbiol"},{"key":"2023053119004053800_ciac682-B30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jac\/dkn235","article-title":"Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland","volume":"62","author":"Palmer","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2023053119004053800_ciac682-B31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/sextrans-2015-052312","article-title":"An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England","volume":"92","author":"Chisholm","year":"2016","journal-title":"Sex Transm Infect"},{"key":"2023053119004053800_ciac682-B32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1473-3099(18)30122-1","article-title":"Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study","volume":"18","author":"Fifer","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2023053119004053800_ciac682-B33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/sextrans-2017-053287","article-title":"Whole-genome sequencing reveals transmission of gonococcal antibiotic resistance among men who have sex with men: an observational study","volume":"94","author":"Kwong","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2023053119004053800_ciac682-B34","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/JCM.03195-15","article-title":"Genomic epidemiology and molecular resistance mechanisms of azithromycin-resistant Neisseria gonorrhoeae in Canada from 1997 to 2014","volume":"54","author":"Demczuk","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2023053119004053800_ciac682-B35","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/infdis\/jiw420","article-title":"Genomic epidemiology of gonococcal resistance to extended-spectrum cephalosporins, macrolides, and fluoroquinolones in the United States, 2000\u20132013","volume":"214","author":"Grad","year":"2016","journal-title":"J Infect Dis"},{"key":"2023053119004053800_ciac682-B36","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3201\/eid2407.172104","article-title":"Effects of sexual network connectivity and antimicrobial drug use on antimicrobial resistance in Neisseria gonorrhoeae","volume":"24","author":"Kenyon","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2023053119004053800_ciac682-B37","doi-asserted-by":"crossref","first-page":"e1005611","DOI":"10.1371\/journal.ppat.1005611","article-title":"Antibiotic-resistant Neisseria gonorrhoeae spread faster with more treatment, not more sexual partners","volume":"12","author":"Fingerhuth","year":"2016","journal-title":"PLoS Pathog"},{"key":"2023053119004053800_ciac682-B38","doi-asserted-by":"crossref","first-page":"e0213312","DOI":"10.1371\/journal.pone.0213312","article-title":"Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016","volume":"14","author":"George","year":"2019","journal-title":"PLoS One"},{"key":"2023053119004053800_ciac682-B39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fmed.2018.00329","article-title":"Antimicrobial consumption and susceptibility of Neisseria gonorrhoeae: a global ecological analysis","volume":"5","author":"Kenyon","year":"2018","journal-title":"Front Med"},{"key":"2023053119004053800_ciac682-B40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/OLQ.0000000000001234","article-title":"Epidemiologic treatment for contacts to Neisseria gonorrhoeae and Chlamydia trachomatis infection in sexually transmitted disease clinic patients in Seattle, WA; 1994 to 2018","volume":"47","author":"Rowlinson","year":"2020","journal-title":"Sex Transm Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac682\/45963547\/ciac682.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/3\/e1270\/50497021\/ciac682.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/3\/e1270\/50497021\/ciac682.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T19:02:03Z","timestamp":1685559723000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/76\/3\/e1270\/6674668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,8,24]]},"published-print":{"date-parts":[[2023,2,8]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac682","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,8,24]]}}}